Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Tuberculosis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 438 articles:
HTML format



Single Articles


    January 2022
  1. LUNGU P, Njelesani E, Sukwa T, Ngalamika O, et al
    Immune correlates of Mycobacterium Tuberculosis patients in Zambia stratified by HIV serostatus and level of immunity-a cross-sectional analytical laboratory based study.
    PLoS One. 2022;17:e0262454.
    PubMed     Abstract available


  2. BURKE RM, Nyirenda S, Twabi HH, Nliwasa M, et al
    Design and protocol for a cluster randomised trial of enhanced diagnostics for tuberculosis screening among people living with HIV in hospital in Malawi (CASTLE study).
    PLoS One. 2022;17:e0261877.
    PubMed     Abstract available


  3. GUO S, Chongsuvivatwong V, Guo M, Lei S, et al
    Yield, NNS and prevalence of screening for DM and hypertension among pulmonary tuberculosis index cases and contacts through single time screening: A contact tracing-based study.
    PLoS One. 2022;17:e0263308.
    PubMed     Abstract available


  4. ADHIKARI N, Bhattarai RB, Basnet R, Joshi LR, et al
    Prevalence and associated risk factors for tuberculosis among people living with HIV in Nepal.
    PLoS One. 2022;17:e0262720.
    PubMed     Abstract available


  5. MATEYO K, Kerkhoff AD, Dunn I, Nteeni MS, et al
    Clinical and radiographic characteristics of presumptive tuberculosis patients previously treated for tuberculosis in Zambia.
    PLoS One. 2022;17:e0263116.
    PubMed     Abstract available


  6. ADMASSU W, Ayelign B, Abebe G, Tadesse M, et al
    Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert(R) MTB/RIF assay among presumptive tuberculosis cases at Jimma University Medical Center, Southwest Ethiopia.
    PLoS One. 2022;17:e0262929.
    PubMed     Abstract available


  7. DE PAIVA JPS, Magalhaes MAFM, Leal TC, da Silva LF, et al
    Time trend, social vulnerability, and identification of risk areas for tuberculosis in Brazil: An ecological study.
    PLoS One. 2022;17:e0247894.
    PubMed     Abstract available


  8. PHUOC LONG N, Heo DY, Park S, Thi Hai Yen N, et al
    Molecular perturbations in pulmonary tuberculosis patients identified by pathway-level analysis of plasma metabolic features.
    PLoS One. 2022;17:e0262545.
    PubMed     Abstract available


  9. WALLIS RS, Ginindza S, Beattie T, Arjun N, et al
    Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial.
    PLoS One. 2022;17:e0252097.
    PubMed     Abstract available


  10. SIMIENEH A, Tadesse M, Kebede W, Gashaw M, et al
    Combination of Xpert(R) MTB/RIF and DetermineTM TB-LAM Ag improves the diagnosis of extrapulmonary tuberculosis at Jimma University Medical Center, Oromia, Ethiopia.
    PLoS One. 2022;17:e0263172.
    PubMed     Abstract available


  11. LAXMESHWAR C, Das M, Mathur T, Israni T, et al
    Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India.
    PLoS One. 2022;17:e0263759.
    PubMed     Abstract available


  12. BROOKS MB, Dubois MM, Malik AA, Ahmed JF, et al
    Age-specific effectiveness of a tuberculosis screening intervention in children.
    PLoS One. 2022;17:e0264216.
    PubMed     Abstract available


  13. GHIMIRE A, Mahendradhata Y, Paudel S, Lama Yonzon C, et al
    Implementation fidelity of tuberculosis preventive therapy for under five children exposed to sputum smear positive pulmonary tuberculosis in Kaski district, Nepal: An implementation research.
    PLoS One. 2022;17:e0263967.
    PubMed     Abstract available


  14. CARNEY T, Rooney JA, Niemand N, Myers B, et al
    Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling.
    PLoS One. 2022;17:e0262440.
    PubMed     Abstract available


  15. ADJOBIMEY M, Ade S, Wachinou P, Esse M, et al
    Prevalence, acceptability, and cost of routine screening for pulmonary tuberculosis among pregnant women in Cotonou, Benin.
    PLoS One. 2022;17:e0264206.
    PubMed     Abstract available


  16. SOEROTO AY, Nurhayati RD, Purwiga A, Lestari BW, et al
    Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia.
    PLoS One. 2022;17:e0263304.
    PubMed     Abstract available


  17. LACOURSE SM, Seko E, Wood R, Bundi W, et al
    Diagnostic performance of oral swabs for non-sputum based TB diagnosis in a TB/HIV endemic setting.
    PLoS One. 2022;17:e0262123.
    PubMed     Abstract available


  18. WATANABE Y, Nakagawa T, Fukai K, Honda T, et al
    Descriptive study of chest x-ray examination in mandatory annual health examinations at the workplace in Japan.
    PLoS One. 2022;17:e0262404.
    PubMed     Abstract available


  19. BELAKEHAL F, Barth SA, Menge C, Mossadak HT, et al
    Evaluation of the discriminatory power of spoligotyping and 19-locus mycobacterial interspersed repetitive unit-variable number of tandem repeat analysis (MIRU-VNTR) of Mycobacterium bovis strains isolated from cattle in Algeria.
    PLoS One. 2022;17:e0262390.
    PubMed     Abstract available


  20. ACKHTER MM, Shahid ASMSB, Ahmed T, Palit P, et al
    Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guerin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh.
    PLoS One. 2022;17:e0262391.
    PubMed     Abstract available


  21. MAGHRADZE N, Jugheli L, Borrell S, Tukvadze N, et al
    Developing customized stepwise MIRU-VNTR typing for tuberculosis surveillance in Georgia.
    PLoS One. 2022;17:e0264472.
    PubMed     Abstract available


  22. WAKJIRA MK, Sandy PT, Mavhandu-Mudzusi AH
    Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia.
    PLoS One. 2022;17:e0262318.
    PubMed     Abstract available


  23. ISLAM MS, Tarannum S, Banu S, Chowdhury KIA, et al
    Preparedness of tertiary care hospitals to implement the national TB infection prevention and control guidelines in Bangladesh: A qualitative exploration.
    PLoS One. 2022;17:e0263115.
    PubMed     Abstract available


  24. DLATU N, Longo-Mbenza B, Apalata T
    Predictors of tuberculosis incidence and the effects of multiple deprivation indices on tuberculosis management in OR Tambo district over a 5-year period.
    PLoS One. 2022;17:e0264811.
    PubMed     Abstract available


  25. NADJIB M, Dewi RK, Setiawan E, Miko TY, et al
    Cost and affordability of scaling up tuberculosis diagnosis using Xpert MTB/RIF testing in West Java, Indonesia.
    PLoS One. 2022;17:e0264912.
    PubMed     Abstract available


  26. SOLTOBEKOVA N, Kozukeev T, Yiehdego G, Labib F, et al
    Time to start of tuberculosis treatment in penitentiary system of Kyrgyz Republic: A retrospective cohort study.
    PLoS One. 2022;17:e0264252.
    PubMed     Abstract available


  27. FLORENTINO JL, Arao RML, Garfin AMC, Gaviola DMG, et al
    Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the Philippines.
    PLoS One. 2022;17:e0264689.
    PubMed     Abstract available


  28. ZHAO D, Zhang H, Cao Q, Wang Z, et al
    The research of ARIMA, GM(1,1), and LSTM models for prediction of TB cases in China.
    PLoS One. 2022;17:e0262734.
    PubMed     Abstract available


  29. CHIHOTA VN, Ntshiqa T, Maenetje P, Mansukhani R, et al
    Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners.
    PLoS One. 2022;17:e0265036.
    PubMed     Abstract available


  30. BROOKS MB, Millones AK, Puma D, Contreras C, et al
    Mapping local hot spots with routine tuberculosis data: A pragmatic approach to identify spatial variability.
    PLoS One. 2022;17:e0265826.
    PubMed     Abstract available


  31. MAYA TG, Komba EV, Mensah GI, Mbelele PM, et al
    Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania.
    PLoS One. 2022;17:e0265358.
    PubMed     Abstract available


  32. TURIMUMAHORO P, Tucker A, Gupta AJ, Tampi RP, et al
    A cost analysis of implementing mobile health facilitated tuberculosis contact investigation in a low-income setting.
    PLoS One. 2022;17:e0265033.
    PubMed     Abstract available


  33. KIM SH, Park YM, Han K, Ko SH, et al
    Association of weight change following smoking cessation with the risk of tuberculosis development: A nationwide population-based cohort study.
    PLoS One. 2022;17:e0266262.
    PubMed     Abstract available


  34. WALLES J, Otero LG, Tesfaye F, Abera A, et al
    Tuberculosis infection and stillbirth in Ethiopia-A prospective cohort study.
    PLoS One. 2022;17:e0261972.
    PubMed     Abstract available


  35. VAN DE WATER BJ, Fulcher I, Cilliers S, Meyer N, et al
    Association of HIV infection and antiretroviral therapy with the occurrence of an unfavorable TB treatment outcome in a rural district hospital in Eastern Cape, South Africa: A retrospective cohort study.
    PLoS One. 2022;17:e0266082.
    PubMed     Abstract available


  36. TAVOSCHI L, Belardi P, Mazzilli S, Manenti F, et al
    An integrated hospital-district performance evaluation for communicable diseases in low-and middle-income countries: Evidence from a pilot in three sub-Saharan countries.
    PLoS One. 2022;17:e0266225.
    PubMed     Abstract available


  37. ATNAFU A, Desta K, Girma S, Hailu D, et al
    Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients.
    PLoS One. 2022;17:e0265499.
    PubMed     Abstract available


  38. GEREMEW D, Geremew H, Tamir M, Adem M, et al
    Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia.
    PLoS One. 2022;17:e0266803.
    PubMed     Abstract available


  39. YANG J, Kim HY, Park S, Sentissi I, et al
    Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco.
    PLoS One. 2022;17:e0267292.
    PubMed     Abstract available


  40. SZKWARKO D, Kim S, Carter EJ, Goldman RE, et al
    Primary care providers' and nurses' knowledge, attitudes, and skills regarding latent TB infection testing and treatment: A qualitative study from Rhode Island.
    PLoS One. 2022;17:e0267029.
    PubMed     Abstract available


  41. VANLEEUW L, Zembe-Mkabile W, Atkins S
    "I'm suffering for food": Food insecurity and access to social protection for TB patients and their households in Cape Town, South Africa.
    PLoS One. 2022;17:e0266356.
    PubMed     Abstract available


  42. MAKESWARAN P, Shah SA, Safian N, Muhamad NA, et al
    Determinants of delayed tuberculosis treatment among patients in Selangor: A study protocol.
    PLoS One. 2022;17:e0266746.
    PubMed     Abstract available


  43. PLASCENCIA HERNANDEZ A, Gonzalez Sanchez RM, Hernandez Canaveral II, Luevanos Velazquez A, et al
    A prevalence study in Guadalajara, Mexico, comparing tuberculin skin test and QuantiFERON-TB Gold In-Tube.
    PLoS One. 2022;17:e0264982.
    PubMed     Abstract available


  44. MERID MW, Muluneh AG, Kassa GM
    Alcohol drinking delays the rate of sputum smear conversion among DR-TB patients in northwest Ethiopia; A retrospective follow-up study.
    PLoS One. 2022;17:e0264852.
    PubMed     Abstract available


  45. DUBALE M, Tadesse M, Berhane M, Mekonnen M, et al
    Stool-based Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children at a teaching and referral hospital in Southwest Ethiopia.
    PLoS One. 2022;17:e0267661.
    PubMed     Abstract available


  46. BENDER IGNACIO RA, Long J, Saha A, Nguyen FK, et al
    Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition.
    PLoS One. 2022;17:e0267729.
    PubMed     Abstract available


  47. DELGADO LG, Postigo M, Cuadrado D, Gil-Casanova S, et al
    Remote analysis of sputum smears for mycobacterium tuberculosis quantification using digital crowdsourcing.
    PLoS One. 2022;17:e0268494.
    PubMed     Abstract available


  48. PEPIN J, Desjardins F, Carignan A, Lambert M, et al
    Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada.
    PLoS One. 2022;17:e0267781.
    PubMed     Abstract available


  49. KAZIBWE A, Oryokot B, Mugenyi L, Kagimu D, et al
    Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study.
    PLoS One. 2022;17:e0266285.
    PubMed     Abstract available


  50. SALOMON A, Law S, Johnson C, Baddeley A, et al
    Interventions to improve linkage along the HIV-tuberculosis care cascades in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267511.
    PubMed     Abstract available


  51. KATHAMUTHU GR, Sridhar R, Baskaran D, Babu S, et al
    Dominant expansion of CD4+, CD8+ T and NK cells expressing Th1/Tc1/Type 1 cytokines in culture-positive lymph node tuberculosis.
    PLoS One. 2022;17:e0269109.
    PubMed     Abstract available


  52. SAGHAZADEH A, Rezaei N
    Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268543.
    PubMed     Abstract available


  53. YANG DL, Li W, Pan MH, Su HX, et al
    Spatial analysis and influencing factors of pulmonary tuberculosis among students in Nanning, during 2012-2018.
    PLoS One. 2022;17:e0268472.
    PubMed     Abstract available


  54. READHEAD A, Flood J, Barry P
    Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014-2017.
    PLoS One. 2022;17:e0268739.
    PubMed     Abstract available


  55. BAKULA Z, Wuyep VB, Bartocha L, Vyazovaya A, et al
    Molecular snapshot of drug-resistant Mycobacterium tuberculosis strains from the Plateau State, Nigeria.
    PLoS One. 2022;17:e0266837.
    PubMed     Abstract available


  56. KHUNDI M, Carpenter JR, Corbett EL, Feasey HRA, et al
    Neighbourhood prevalence-to-notification ratios for adult bacteriologically-confirmed tuberculosis reveals hotspots of underdiagnosis in Blantyre, Malawi.
    PLoS One. 2022;17:e0268749.
    PubMed     Abstract available


  57. ABEBAW Y, Kebede A, Eshetu K, Tesfaye E, et al
    Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia.
    PLoS One. 2022;17:e0269601.
    PubMed     Abstract available


  58. MEAZA A, Tola HH, Eshetu K, Mindaye T, et al
    Tuberculosis among refugees and migrant populations: Systematic review.
    PLoS One. 2022;17:e0268696.
    PubMed     Abstract available


  59. BILCHUT AH, Mekonnen AG, Assen TA
    Knowledge of symptoms and delays in diagnosis of extrapulmonary tuberculosis patients in North Shewa zone, Ethiopia.
    PLoS One. 2022;17:e0270002.
    PubMed     Abstract available


  60. YOUN HM, Shin MK, Jeong D, Kim HJ, et al
    Risk factors associated with tuberculosis recurrence in South Korea determined using a nationwide cohort study.
    PLoS One. 2022;17:e0268290.
    PubMed     Abstract available


  61. XI Y, Zhang W, Qiao RJ, Tang J, et al
    Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis.
    PLoS One. 2022;17:e0270003.
    PubMed     Abstract available


  62. MOLLA KA, Reta MA, Ayene YY
    Prevalence of multidrug-resistant tuberculosis in East Africa: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0270272.
    PubMed     Abstract available


  63. REN C, Tang J, Xia L
    Interferon gamma release assays for diagnosis of osteoarticular tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269234.
    PubMed     Abstract available


  64. EVANS EE, Avaliani T, Gujabidze M, Bakuradze T, et al
    Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance.
    PLoS One. 2022;17:e0270201.
    PubMed     Abstract available


  65. AMOUR MA, Rees CA, Munseri PJ, Said J, et al
    Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    PLoS One. 2022;17:e0268685.
    PubMed     Abstract available


  66. INDRATI AR, Sumarpo A, Atmadja P, Wisesa RR, et al
    Exploring alternative cytokines as potential biomarkers for latent tuberculosis infection in pregnant women.
    PLoS One. 2022;17:e0270552.
    PubMed     Abstract available


  67. YAMATANI I, Komiya K, Shuto H, Yamanaka M, et al
    Correlation between tuberculosis-specific interferon-gamma release assay and intrathoracic calcification: A cross-sectional study.
    PLoS One. 2022;17:e0270785.
    PubMed     Abstract available


  68. AMEDE PO, Adedire E, Usman A, Ameh CA, et al
    Drug-susceptible tuberculosis treatment outcomes and its associated factors among inmates in prison settings in Bauchi State, Nigeria, 2014-2018.
    PLoS One. 2022;17:e0270819.
    PubMed     Abstract available


  69. KHAN MK, Islam MN, Hassan J, Paul SK, et al
    Hierarchical true prevalence, risk factors and clinical symptoms of tuberculosis among suspects in Bangladesh.
    PLoS One. 2022;17:e0262978.
    PubMed     Abstract available


  70. WIDYANINGSIH V, Febrinasari RP, Sari V, Augustania C, et al
    Potential and challenges for an integrated management of tuberculosis, diabetes mellitus, and hypertension: A scoping review protocol.
    PLoS One. 2022;17:e0271323.
    PubMed     Abstract available


  71. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis.
    PLoS One. 2022;17:e0268483.
    PubMed     Abstract available


  72. ZIKO LM, Hoffman TW, Fwoloshi S, Chanda D, et al
    Aetiology and prognosis of community-acquired pneumonia at the Adult University Teaching Hospital in Zambia.
    PLoS One. 2022;17:e0271449.
    PubMed     Abstract available


  73. KACZMARKOWSKA A, Didkowska A, Brzezinska S, Klich D, et al
    Could the type and severity of gross lesions in pig lymph nodes play a role in the detection of Mycobacterium avium?
    PLoS One. 2022;17:e0269912.
    PubMed     Abstract available


  74. LUNGU P, Mushota K, Njelesani E, Sukwa T, et al
    Expression of mycobacterium tuberculosis induced SOCS3 and STAT3 and the implications on innate immunity in TB patients vs healthy contacts in high TB/HIV endemic setting: A cross-sectional analytical study.
    PLoS One. 2022;17:e0263624.
    PubMed     Abstract available


  75. HANSEN J, Kolbe K, Konig IR, Scherliess R, et al
    Lipobiotin-capture magnetic bead assay for isolation, enrichment and detection of Mycobacterium tuberculosis from saliva.
    PLoS One. 2022;17:e0265554.
    PubMed     Abstract available


  76. WADEMAN DT, Hoddinott G, Purchase SE, Seddon JA, et al
    Practical and psychosocial challenges faced by caregivers influence the acceptability of multidrug-resistant tuberculosis preventive therapy for young children.
    PLoS One. 2022;17:e0268560.
    PubMed     Abstract available


  77. PERESU E, Heunis JC, Kigozi NG, De Graeve D, et al
    Knowledge, attitudes and practices of community treatment supporters administering multidrug-resistant tuberculosis injections: A cross-sectional study in rural Eswatini.
    PLoS One. 2022;17:e0271362.
    PubMed     Abstract available


  78. PONGPEERADECH N, Kasetchareo Y, Chuchottaworn C, Lawpoolsri S, et al
    Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand.
    PLoS One. 2022;17:e0271130.
    PubMed     Abstract available


  79. LAHOOD A, Rahman R, McKenna L, Frick M, et al
    Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.
    PLoS One. 2022;17:e0271102.
    PubMed     Abstract available


  80. MESFIN EA, Merker M, Beyene D, Tesfaye A, et al
    Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    PLoS One. 2022;17:e0271508.
    PubMed     Abstract available


  81. FEKADU G, Yao J, You JHS
    Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis.
    PLoS One. 2022;17:e0272770.
    PubMed     Abstract available


  82. SADEGHI K, Poorolajal J, Doosti-Irani A
    Prevalence of modifiable risk factors of tuberculosis and their population attributable fraction in Iran: A cross-sectional study.
    PLoS One. 2022;17:e0271511.
    PubMed     Abstract available


  83. SENEADZA NAH, Kwara A, Lauzardo M, Prins C, et al
    Assessing risk factors for latent and active tuberculosis among persons living with HIV in Florida: A comparison of self-reports and medical records.
    PLoS One. 2022;17:e0271917.
    PubMed     Abstract available


  84. GETU A, Wolde HF, Animut Y, Kibret AA, et al
    Incidence and predictors of Tuberculosis among patients enrolled in Anti-Retroviral Therapy after universal test and treat program, Addis Ababa, Ethiopia. A retrospective follow -up study.
    PLoS One. 2022;17:e0272358.
    PubMed     Abstract available


  85. KASSA M, Desta K, Ambachew R, Gebreyohannes Z, et al
    Magnitude of Mycobacterium tuberculosis, drug resistance and associated factors among presumptive tuberculosis patients at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    PLoS One. 2022;17:e0272459.
    PubMed     Abstract available


  86. DANESHFAR S, Khosravi AD, Hashemzadeh M
    Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
    PLoS One. 2022;17:e0267320.
    PubMed     Abstract available


  87. ANLEY DT, Akalu TY, Merid MW, Dessie AM, et al
    Development and validation of a nomogram for the prediction of late culture conversion among multi-drug resistant tuberculosis patients in North West Ethiopia: An application of prediction modelling.
    PLoS One. 2022;17:e0272877.
    PubMed     Abstract available


  88. RACHOW A, Saathoff E, Mindru R, Popescu O, et al
    Diagnostic performance of the AID line probe assay in the detection of Mycobacterium tuberculosis and drug resistance in Romanian patients with presumed TB.
    PLoS One. 2022;17:e0271297.
    PubMed     Abstract available


  89. NIKITUSHKIN V, Shleeva M, Loginov D, Dycka F F, et al
    Shotgun proteomic profiling of dormant, 'non-culturable' Mycobacterium tuberculosis.
    PLoS One. 2022;17:e0269847.
    PubMed     Abstract available


  90. MIN J, Kim HW, Kang JY, Kim SK, et al
    Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.
    PLoS One. 2022;17:e0273263.
    PubMed     Abstract available


  91. GEBRETNSAE H, Hadgu T, Ayele BG, Abraha A, et al
    Health extension workers contribution on tuberculosis case notification in Tigray region, Northern Ethiopia: A concurrent mixed method study.
    PLoS One. 2022;17:e0271968.
    PubMed     Abstract available


  92. ARAIA ZZ, Kibreab F, Kibrom AA, Mebrahtu AH, et al
    Determinants of unsuccessful tuberculosis treatment outcome in Northern Red Sea region, Eritrea.
    PLoS One. 2022;17:e0273069.
    PubMed     Abstract available


  93. AMEDEO A, Beci G, Giglia M, Lombardi G, et al
    Evaluation of trace calls by Xpert MTB/RIF ultra for clinical management in low TB burden settings.
    PLoS One. 2022;17:e0272997.
    PubMed     Abstract available


  94. ACEN EL, Kateete DP, Worodria W, Olum R, et al
    Evaluation of circulating serum cathelicidin levels as a potential biomarker to discriminate between active and latent tuberculosis in Uganda.
    PLoS One. 2022;17:e0272788.
    PubMed     Abstract available


  95. FISCHER H, Qian L, Skarbinski J, Bruxvoort KJ, et al
    Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems.
    PLoS One. 2022;17:e0273363.
    PubMed     Abstract available


  96. MINGCHAY P, Paitoonpong L, Kawkitinarong K, Ohata PJ, et al
    Tuberculosis at a university hospital, Thailand: A surprising incidence of TB among a new generation of highly exposed health care workers who may be asymptomatic.
    PLoS One. 2022;17:e0273027.
    PubMed     Abstract available


  97. SAELEE C, Hanthamrongwit J, Soe PT, Khaenam P, et al
    Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
    PLoS One. 2022;17:e0273517.
    PubMed     Abstract available


  98. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Persistent expression of activation markers on Mycobacterium tuberculosis-specific CD4 T cells in smear negative TB patients.
    PLoS One. 2022;17:e0271234.
    PubMed     Abstract available


  99. SHI F, Qiu X, Yu M, Huang Y, et al
    Tuberculosis-specific antigen stimulated and unstimulated interferon-gamma for tuberculous meningitis diagnosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0273834.
    PubMed     Abstract available


  100. BARAL S, Rao A, Rwema JOT, Lyons C, et al
    Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.
    PLoS One. 2022;17:e0273389.
    PubMed     Abstract available


  101. KASWASWA K, MacPherson P, Kumwenda M, Mpunga J, et al
    Effect of patient-delivered household contact tracing and prevention for tuberculosis: A household cluster-randomised trial in Malawi.
    PLoS One. 2022;17:e0269219.
    PubMed     Abstract available


  102. WIJAYANTI E, Bachtiar A, Achadi A, Rachmawati UA, et al
    Mobile application development for improving medication safety in tuberculosis patients: A quasi-experimental study protocol.
    PLoS One. 2022;17:e0272616.
    PubMed     Abstract available


  103. GETAHUN M, Blumberg HM, Ameni G, Beyene D, et al
    Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    PLoS One. 2022;17:e0274426.
    PubMed     Abstract available


  104. KATENDE KK, Amiyo MR, Nabukeera S, Mugisa I, et al
    Design, development, and testing of a voice-text mobile health application to support Tuberculosis medication adherence in Uganda.
    PLoS One. 2022;17:e0274112.
    PubMed     Abstract available


  105. MVELASE NR, Singh R, Swe Swe-Han K, Mlisana KP, et al
    Pyrazinamide resistance in rifampicin discordant tuberculosis.
    PLoS One. 2022;17:e0274688.
    PubMed     Abstract available


  106. LEDESMA JR, Lurie P, Yorlets RR, Daly G, et al
    Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
    PLoS One. 2022;17:e0274900.
    PubMed     Abstract available


  107. MISRA S, Misra N, Seepamore B, Holloway K, et al
    "I would watch her with awe as she swallowed the first handful": A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa.
    PLoS One. 2022;17:e0274741.
    PubMed     Abstract available


  108. ACHARYA S, Deshpande P, Asirvatham ES, Palkar A, et al
    Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India.
    PLoS One. 2022;17:e0273970.
    PubMed     Abstract available


  109. CANTERA JL, Lillis LM, Peck RB, Moreau E, et al
    Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
    PLoS One. 2022;17:e0274415.
    PubMed     Abstract available


  110. ARIF S, Akhter M, Khaliq A, Akhtar MW, et al
    Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response.
    PLoS One. 2022;17:e0271126.
    PubMed     Abstract available


  111. SCRIVO R, Molteni E, Castellani C, Altobelli A, et al
    Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
    PLoS One. 2022;17:e0275329.
    PubMed     Abstract available


  112. HERRERA M, Keynan Y, McLaren PJ, Isaza JP, et al
    Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study.
    PLoS One. 2022;17:e0274257.
    PubMed     Abstract available


  113. GOMES I, Dong C, Vandewalle P, Khan A, et al
    Comparative assessment of the cost-effectiveness of Tuberculosis (TB) active case-finding interventions: A systematic analysis of TB REACH wave 5 projects.
    PLoS One. 2022;17:e0270816.
    PubMed     Abstract available


  114. ALEMAYEHU A, Kebede A, Neway S, Tesfaye E, et al
    A glimpse into the genotype and clinical importance of non tuberculous mycobacteria among pulmonary tuberculosis patients: The case of Ethiopia.
    PLoS One. 2022;17:e0275159.
    PubMed     Abstract available


  115. G SG, Mannam P, Kumar V, George T, et al
    Absence of posterior pituitary bright spot in adults with CNS tuberculosis: A case-control study.
    PLoS One. 2022;17:e0275460.
    PubMed     Abstract available


  116. MALE HERE RR, Ryan E, Breslin P, Frankena K, et al
    Revisiting the relative effectiveness of slaughterhouses in Ireland to detect tuberculosis lesions in cattle (2014-2018).
    PLoS One. 2022;17:e0275259.
    PubMed     Abstract available


  117. DE HAAS P, Yenew B, Diriba G, Amare M, et al
    The Simple One-step stool processing method for detection of Pulmonary tuberculosis: A study protocol to assess the robustness, stool storage conditions and sampling strategy for global implementation and scale-up.
    PLoS One. 2022;17:e0264103.
    PubMed     Abstract available


  118. GAUTAM US, Asrican R, Sempowski GD
    Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system.
    PLoS One. 2022;17:e0276130.
    PubMed     Abstract available


  119. BAL C, Gompelmann D, Krebs M, Antoniewicz L, et al
    Associations of hyponatremia and SIADH with increased mortality, young age and infection parameters in patients with tuberculosis.
    PLoS One. 2022;17:e0275827.
    PubMed     Abstract available


  120. HOLMES RH, Sun S, Kazi S, Ranganathan S, et al
    Management of tuberculosis infection in Victorian children: A retrospective clinical audit of factors affecting treatment completion.
    PLoS One. 2022;17:e0275789.
    PubMed     Abstract available


  121. NYASULU PS, Ngasama E, Tamuzi JL, Sigwadhi LN, et al
    Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
    PLoS One. 2022;17:e0274549.
    PubMed     Abstract available


  122. MAHMUD S, Mohsin M, Irfan SH, Muyeed A, et al
    Knowledge, attitude, practices, and determinants of them toward tuberculosis among social media users in Bangladesh: A cross-sectional study.
    PLoS One. 2022;17:e0275344.
    PubMed     Abstract available


  123. AMIN AG, De P, Graham B, Jensen BL, et al
    Overcome low levels of detection limit and choice of antibody affects detection of lipoarabinomannan in pediatric tuberculosis.
    PLoS One. 2022;17:e0275838.
    PubMed     Abstract available


  124. KAKINDA M, Tugumisirize D, Nyombi A, Mugisha M, et al
    Comparison of tests done, and tuberculosis cases detected by Xpert(R) MTB/RIF and Xpert(R) MTB/RIF-Ultra in Uganda.
    PLoS One. 2022;17:e0275960.
    PubMed     Abstract available


  125. SANTIN M, Perez-Recio S, Grijota MD, Anibarro L, et al
    Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
    PLoS One. 2022;17:e0276387.
    PubMed     Abstract available


  126. AL-MUTAIRI NM, Ahmad S, Mokaddas E, Al-Hajoj S, et al
    First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.
    PLoS One. 2022;17:e0276487.
    PubMed     Abstract available


  127. ULAIN N, Ali A, Khan M, Ullah Z, et al
    Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates.
    PLoS One. 2022;17:e0276064.
    PubMed     Abstract available


  128. SINGH K, Kumar R, Umam F, Kapoor P, et al
    Distinct and shared B cell responses of tuberculosis patients and their household contacts.
    PLoS One. 2022;17:e0276610.
    PubMed     Abstract available


  129. HUANG Y, Darr CM, Gangopadhyay K, Gangopadhyay S, et al
    Applications of machine learning tools for ultra-sensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of tuberculosis.
    PLoS One. 2022;17:e0275658.
    PubMed     Abstract available


  130. SHAMPUTA IC, Nguyen DTK, Higazy D, Abdelhadi A, et al
    Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
    PLoS One. 2022;17:e0277255.
    PubMed     Abstract available


  131. TORNU E, Quarcoopome L
    Correlates of quality of life among persons living with tuberculosis: A cross-sectional study.
    PLoS One. 2022;17:e0277192.
    PubMed     Abstract available


  132. SIME T, Oljira L, Diriba A, Firdisa G, et al
    Effect of active tuberculosis on the survival of HIV-infected adult patients who initiated antiretroviral therapy at public hospitals of Eastern Ethiopia: A retrospective cohort study.
    PLoS One. 2022;17:e0277021.
    PubMed     Abstract available


  133. KIM HB, Bacik JP, Wu R, Jha RK, et al
    Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase.
    PLoS One. 2022;17:e0277670.
    PubMed     Abstract available


  134. MESHESHA MD
    Predictors of sputum culture conversion time among MDR/RR TB patients on treatment in a low-income setting.
    PLoS One. 2022;17:e0277642.
    PubMed     Abstract available


  135. BAIRD K, Said H, Koornhof HJ, Duse AG, et al
    Tuberculosis control at a South African correctional centre: Diagnosis, treatment and strain characterisation.
    PLoS One. 2022;17:e0277459.
    PubMed     Abstract available



  136. Expression of Concern: Secretory Phosphatases Deficient Mutant of Mycobacterium tuberculosis Imparts Protection at the Primary Site of Infection in Guinea Pigs.
    PLoS One. 2022;17:e0277782.
    PubMed    


  137. COCCIA M, Burny W, Demoitie MA, Gillard P, et al
    Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
    PLoS One. 2022;17:e0276505.
    PubMed     Abstract available


  138. RODRIGUEZ CA, Lodi S, Horsburgh CR, Bastard M, et al
    Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion.
    PLoS One. 2022;17:e0276457.
    PubMed     Abstract available


  139. HUDDART S, Geocaniga-Gaviola DM, Crowder R, Lim AR, et al
    Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines.
    PLoS One. 2022;17:e0277078.
    PubMed     Abstract available


  140. DIRIBA G, Alemu A, Eshetu K, Yenew B, et al
    Bacteriologically confirmed extrapulmonary tuberculosis and the associated risk factors among extrapulmonary tuberculosis suspected patients in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0276701.
    PubMed     Abstract available


  141. ABAYNEH M, Teressa M
    Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia: An institution based cross-sectional study.
    PLoS One. 2022;17:e0277536.
    PubMed     Abstract available


  142. MEIER S, Seddon JA, Maasdorp E, Kleynhans L, et al
    Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis.
    PLoS One. 2022;17:e0278295.
    PubMed     Abstract available


  143. ALEMU A, Bitew ZW, Seid G, Diriba G, et al
    Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
    PLoS One. 2022;17:e0277807.
    PubMed     Abstract available


  144. KHAMIS KM, Kadir Shahar H, Abdul Manaf R, Hamdan HM, et al
    Effectiveness of education intervention of tuberculosis treatment adherence in Khartoum State: A study protocol for a randomized control trial.
    PLoS One. 2022;17:e0277888.
    PubMed     Abstract available


    January 2021
  145. AHMAD N, Baharom M, Aizuddin AN, Ramli R, et al
    Sex-related differences in smear-positive pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: Prevalence and associated factors.
    PLoS One. 2021;16:e0245304.
    PubMed     Abstract available


  146. HASSUNA NA, El Feky M, Hussein AARM, Mahmoud MA, et al
    Interleukin-18 and interferon-gamma single nucleotide polymorphisms in Egyptian patients with tuberculosis.
    PLoS One. 2021;16:e0244949.
    PubMed     Abstract available


  147. MARIN AV, Rastogi N, Couvin D, Mape V, et al
    First approach to the population structure of Mycobacterium tuberculosis complex in the indigenous population in Puerto Narino-Amazonas, Colombia.
    PLoS One. 2021;16:e0245084.
    PubMed     Abstract available


  148. KIM J, Park BG, Lim DH, Jang WS, et al
    Development and evaluation of a multiplex loop-mediated isothermal amplification (LAMP) assay for differentiation of Mycobacterium tuberculosis and non-tuberculosis mycobacterium in clinical samples.
    PLoS One. 2021;16:e0244753.
    PubMed     Abstract available


  149. SHANKAR S U, Kumar AMV, Venkateshmurthy NS, Nair D, et al
    Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing?
    PLoS One. 2021;16:e0244785.
    PubMed     Abstract available


  150. ASEMAHAGN MA, Alene GD, Yimer SA
    Spatial-temporal clustering of notified pulmonary tuberculosis and its predictors in East Gojjam Zone, Northwest Ethiopia.
    PLoS One. 2021;16:e0245378.
    PubMed     Abstract available


  151. KHALIQ A, Ravindran R, Afzal S, Jena PK, et al
    Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.
    PLoS One. 2021;16:e0245534.
    PubMed     Abstract available


  152. THAYER MB, Parish T
    Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0239353.
    PubMed     Abstract available


  153. OLADIMEJI O, Adepoju V, Anyiam FE, San JE, et al
    Treatment outcomes of drug susceptible Tuberculosis in private health facilities in Lagos, South-West Nigeria.
    PLoS One. 2021;16:e0244581.
    PubMed     Abstract available


  154. ARNOLD ME, Courcier EA, Stringer LA, McCormick CM, et al
    A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).
    PLoS One. 2021;16:e0246141.
    PubMed     Abstract available


  155. CHUNG HS, Bae S, Kim I, Ahn HY, et al
    Unexpected exposure to Mycobacterium tuberculosis during bronchoscopy using radial probe endobronchial ultrasound.
    PLoS One. 2021;16:e0246371.
    PubMed     Abstract available


  156. DAGNE B, Desta K, Fekade R, Amare M, et al
    The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia.
    PLoS One. 2021;16:e0245687.
    PubMed     Abstract available


  157. LOPEZ K, Arriaga MB, Aliaga JG, Barreda NN, et al
    Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima-Peru.
    PLoS One. 2021;16:e0243184.
    PubMed     Abstract available


  158. SORSA A, Kaso M
    Diagnostic performance of GeneXpert in tuberculosis-HIV co-infected patients at Asella Teaching and Referral Hospital, Southeastern Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0242205.
    PubMed     Abstract available


  159. XIA T, Chen J, Rui J, Li J, et al
    What affected Chinese parents' decisions about tuberculosis (TB) treatment: Implications based on a cross-sectional survey.
    PLoS One. 2021;16:e0245691.
    PubMed     Abstract available


  160. GAUTAM N, Karki RR, Khanam R
    Knowledge on tuberculosis and utilization of DOTS service by tuberculosis patients in Lalitpur District, Nepal.
    PLoS One. 2021;16:e0245686.
    PubMed     Abstract available


  161. LIM RK, Semitala FC, Atuhumuza E, Sabiti L, et al
    Patient choice improves self-efficacy and intention to complete tuberculosis preventive therapy in a routine HIV program setting in Uganda.
    PLoS One. 2021;16:e0246113.
    PubMed     Abstract available


  162. SHIN HJ, Chang JS, Kim MS, Koh BG, et al
    Hypersensitivity reactions to multiple anti-tuberculosis drugs.
    PLoS One. 2021;16:e0246291.
    PubMed     Abstract available


  163. KHAN MS, Rego S, Rajal JB, Bond V, et al
    Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries.
    PLoS One. 2021;16:e0244936.
    PubMed     Abstract available


  164. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0245458.
    PubMed     Abstract available


  165. SOEROTO AY, Pratiwi C, Santoso P, Lestari BW, et al
    Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.
    PLoS One. 2021;16:e0246284.
    PubMed     Abstract available


  166. YUEN CM, Millones AK, Puma D, Jimenez J, et al
    Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru.
    PLoS One. 2021;16:e0247411.
    PubMed     Abstract available


  167. KASSA GM, Merid MW, Muluneh AG, Wolde HF, et al
    Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
    PLoS One. 2021;16:e0246938.
    PubMed     Abstract available


  168. NAZNEEN A, Tarannum S, Chowdhury KIA, Islam MT, et al
    Implementation status of national tuberculosis infection control guidelines in Bangladeshi hospitals.
    PLoS One. 2021;16:e0246923.
    PubMed     Abstract available


  169. EDWARDS BD, Edwards J, Cooper R, Kunimoto D, et al
    Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting.
    PLoS One. 2021;16:e0246993.
    PubMed     Abstract available


  170. ISLAM MN, Khan MK, Khan MFR, Kostoulas P, et al
    Risk factors and true prevalence of bovine tuberculosis in Bangladesh.
    PLoS One. 2021;16:e0247838.
    PubMed     Abstract available


  171. HENNEBERG M, Holloway-Kew K, Lucas T
    Human major infections: Tuberculosis, treponematoses, leprosy-A paleopathological perspective of their evolution.
    PLoS One. 2021;16:e0243687.
    PubMed     Abstract available


  172. FANG Y, Ma Y, Lu Q, Sun J, et al
    An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016-2019.
    PLoS One. 2021;16:e0247564.
    PubMed     Abstract available


  173. LAZARUS G, Tjoa K, Iskandar AWB, Louisa M, et al
    The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248017.
    PubMed     Abstract available


  174. LANDSMAN D, Abdelbasit A, Wang C, Guerzhoy M, et al
    Cohort profile: St. Michael's Hospital Tuberculosis Database (SMH-TB), a retrospective cohort of electronic health record data and variables extracted using natural language processing.
    PLoS One. 2021;16:e0247872.
    PubMed     Abstract available


  175. TOMAZ APO, Raboni SM, Kussen GMB, da Silva Nogueira K, et al
    The Xpert(R) MTB/RIF diagnostic test for pulmonary and extrapulmonary tuberculosis in immunocompetent and immunocompromised patients: Benefits and experiences over 2 years in different clinical contexts.
    PLoS One. 2021;16:e0247185.
    PubMed     Abstract available


  176. BIERMANN O, Kluppelberg R, Lonnroth K, Viney K, et al
    'A double-edged sword': Perceived benefits and harms of active case-finding for people with presumptive tuberculosis and communities-A qualitative study based on expert interviews.
    PLoS One. 2021;16:e0247568.
    PubMed     Abstract available


  177. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    PubMed     Abstract available


  178. HOHLFELD ASJ, Mathebula L, Pienaar ED, Abrams A, et al
    Tuberculosis treatment intervention trials in Africa: A cross-sectional bibliographic study and spatial analysis.
    PLoS One. 2021;16:e0248621.
    PubMed     Abstract available


  179. OHENE SA, Bonsu F, Adusi-Poku Y, Dzata F, et al
    Case finding of tuberculosis among mining communities in Ghana.
    PLoS One. 2021;16:e0248718.
    PubMed     Abstract available


  180. SMITH GC, Budgey R
    Simulating the next steps in badger control for bovine tuberculosis in England.
    PLoS One. 2021;16:e0248426.
    PubMed     Abstract available


  181. ANDARGIE A, Molla A, Tadese F, Zewdie S, et al
    Lost to follow-up and associated factors among patients with drug resistant tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0248687.
    PubMed     Abstract available


  182. CHARLES M, Richard M, Reichler MR, Koama JB, et al
    Treatment success for patients with tuberculosis receiving care in areas severely affected by Hurricane Matthew - Haiti, 2016.
    PLoS One. 2021;16:e0247750.
    PubMed     Abstract available


  183. AMEKE S, Asare P, Aboagye SY, Otchere ID, et al
    Molecular epidemiology of Mycobacterium tuberculosis complex in the Volta Region of Ghana.
    PLoS One. 2021;16:e0238898.
    PubMed     Abstract available


  184. ROSENFELD G, Gabrielian A, Wang Q, Gu J, et al
    Radiologist observations of computed tomography (CT) images predict treatment outcome in TB Portals, a real-world database of tuberculosis (TB) cases.
    PLoS One. 2021;16:e0247906.
    PubMed     Abstract available


  185. ABDU M, Ali Y, Anteneh S, Yesuf M, et al
    Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
    PLoS One. 2021;16:e0248490.
    PubMed     Abstract available


  186. HUDDART S, Singh M, Jha N, Benedetti A, et al
    Case fatality and recurrent tuberculosis among patients managed in the private sector: A cohort study in Patna, India.
    PLoS One. 2021;16:e0249225.
    PubMed     Abstract available


  187. HAN WM, Mahikul W, Pouplin T, Lawpoolsri S, et al
    Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach.
    PLoS One. 2021;16:e0248846.
    PubMed     Abstract available


  188. HERMAN B, Sirichokchatchawan W, Pongpanich S, Nantasenamat C, et al
    Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249243.
    PubMed     Abstract available


  189. HEFFERNAN C, Paulsen C, Asadi L, Egedahl ML, et al
    Individual and public health consequences associated with a missed diagnosis of pulmonary tuberculosis in the emergency department: A retrospective cohort study.
    PLoS One. 2021;16:e0248493.
    PubMed     Abstract available


  190. WOLDESEMAYAT EM, Azeze Z
    Treatment outcome of tuberculosis at Dilla Referral Hospital, Gedeo Zone, southern Ethiopia: A retrospective study.
    PLoS One. 2021;16:e0249369.
    PubMed     Abstract available


  191. MIRZAZADEH A, Kahn JG, Haddad MB, Hill AN, et al
    State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    PLoS One. 2021;16:e0249012.
    PubMed     Abstract available


  192. STEFANESCU S, Cocos R, Turcu-Stiolica A, Mahler B, et al
    Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania.
    PLoS One. 2021;16:e0249301.
    PubMed     Abstract available


  193. XU F, Tian L, Li Y, Zhang X, et al
    High prevalence of extrapulmonary tuberculosis in dairy farms: Evidence for possible gastrointestinal transmission.
    PLoS One. 2021;16:e0249341.
    PubMed     Abstract available


  194. DE MENDONCA EB, Schmaltz CA, Sant'Anna FM, Vizzoni AG, et al
    Correction: Anemia in tuberculosis cases: A biomarker of severity?
    PLoS One. 2021;16:e0249545.
    PubMed     Abstract available


  195. THIEL BA, Worodria W, Nalukwago S, Nsereko M, et al
    Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249477.
    PubMed     Abstract available


  196. SANTOS FLD, Souza LLL, Bruce ATI, Crispim JA, et al
    Patients' perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study.
    PLoS One. 2021;16:e0249822.
    PubMed     Abstract available


  197. HEWAGE S, Somasundaram N, Ratnasamy V, Ranathunga I, et al
    Active screening of patients with diabetes mellitus for pulmonary tuberculosis in a tertiary care hospital in Sri Lanka.
    PLoS One. 2021;16:e0249787.
    PubMed     Abstract available


  198. MEKKAOUI L, Hallin M, Mouchet F, Payen MC, et al
    Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium.
    PLoS One. 2021;16:e0249734.
    PubMed     Abstract available


  199. GWITIRA I, Karumazondo N, Shekede MD, Sandy C, et al
    Spatial patterns of pulmonary tuberculosis (TB) cases in Zimbabwe from 2015 to 2018.
    PLoS One. 2021;16:e0249523.
    PubMed     Abstract available


  200. JAKHAR S, Sakamuri R, Vu D, Dighe P, et al
    Interaction of amphiphilic lipoarabinomannan with host carrier lipoproteins in tuberculosis patients: Implications for blood-based diagnostics.
    PLoS One. 2021;16:e0243337.
    PubMed     Abstract available


  201. SPEKKER O, Kis L, Deak A, Makai E, et al
    An unusual case of childhood osteoarticular tuberculosis from the Arpadian Age cemetery of Gyorszentivan-Revhegyi tag (Gyor-Moson-Sopron county, Hungary).
    PLoS One. 2021;16:e0249939.
    PubMed     Abstract available


  202. CHAVES-TORRES NM, Fadul S, Patino J, Netto E, et al
    Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0249565.
    PubMed     Abstract available


  203. MCCALLAN L, Brooks C, Barry C, Couzens C, et al
    Serological test performance for bovine tuberculosis in cattle from herds with evidence of on-going infection in Northern Ireland.
    PLoS One. 2021;16:e0245655.
    PubMed     Abstract available


  204. RAISANEN PE, Haanpera M, Soini H, Ruutu P, et al
    Transmission of tuberculosis between foreign-born and Finnish-born populations in Finland, 2014-2017.
    PLoS One. 2021;16:e0250674.
    PubMed     Abstract available


  205. CARTER BB, Zhang Y, Zou H, Zhang C, et al
    Survival analysis of patients with tuberculosis and risk factors for multidrug-resistant tuberculosis in Monrovia, Liberia.
    PLoS One. 2021;16:e0249474.
    PubMed     Abstract available


  206. SAKTIAWATI AMI, Triyana K, Wahyuningtias SD, Dwihardiani B, et al
    eNose-TB: A trial study protocol of electronic nose for tuberculosis screening in Indonesia.
    PLoS One. 2021;16:e0249689.
    PubMed     Abstract available


  207. OLIVEIRA O, Gaio R, Correia-Neves M, Rito T, et al
    Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000-2016.
    PLoS One. 2021;16:e0250028.
    PubMed     Abstract available


  208. COLY S, Garrido M, Abrial D, Yao AF, et al
    Bayesian hierarchical models for disease mapping applied to contagious pathologies.
    PLoS One. 2021;16:e0222898.
    PubMed     Abstract available


  209. MINJA LT, Hella J, Mbwambo J, Nyandindi C, et al
    High burden of tuberculosis infection and disease among people receiving medication-assisted treatment for substance use disorder in Tanzania.
    PLoS One. 2021;16:e0250038.
    PubMed     Abstract available


  210. HO LJ, Yang HY, Chung CH, Chang WC, et al
    Increased risk of secondary lung cancer in patients with tuberculosis: A nationwide, population-based cohort study.
    PLoS One. 2021;16:e0250531.
    PubMed     Abstract available


  211. NGUYEN LH, Tran PTM, Dam TA, Forse RJ, et al
    Assessing private provider perceptions and the acceptability of video observed treatment technology for tuberculosis treatment adherence in three cities across Viet Nam.
    PLoS One. 2021;16:e0250644.
    PubMed     Abstract available


  212. BIGIO J, Kohli M, Klinton JS, MacLean E, et al
    Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review.
    PLoS One. 2021;16:e0251236.
    PubMed     Abstract available


  213. WOLDEYOHANNES D, Tekalegn Y, Sahiledengle B, Assefa T, et al
    Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
    PLoS One. 2021;16:e0250804.
    PubMed     Abstract available


  214. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0250933.
    PubMed     Abstract available


  215. JARSBERG LG, Kedia K, Wendler J, Wright AT, et al
    Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region.
    PLoS One. 2021;16:e0250586.
    PubMed     Abstract available


  216. NERLICH AG, Kirchhoff SM, Panzer S, Lehn C, et al
    Chronic active non-lethal human-type tuberculosis in a high royal Bavarian officer of Napoleonic times-a mummy study.
    PLoS One. 2021;16:e0249955.
    PubMed     Abstract available


  217. LEE HN, Kim JI, Kim YH
    Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0250616.
    PubMed     Abstract available


  218. JADHAV R, Gallardo-Macias R, Kumar G, Daher SS, et al
    Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0249841.
    PubMed     Abstract available


  219. KABUGO J, Namutebi J, Mujuni D, Nsawotebba A, et al
    Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory.
    PLoS One. 2021;16:e0251691.
    PubMed     Abstract available


  220. ROBSKY KO, Isooba D, Nakasolya O, Mukiibi J, et al
    Characterization of geographic mobility among participants in facility- and community-based tuberculosis case finding in urban Uganda.
    PLoS One. 2021;16:e0251806.
    PubMed     Abstract available


  221. FOSTER N, Cunnama L, McCarthy K, Ramma L, et al
    Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.
    PLoS One. 2021;16:e0251547.
    PubMed     Abstract available


  222. ARAYA BT, Ali KE, Geleta DA, Tekele SG, et al
    Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of Mycobacterium Tuberculosis and resistance markers in sputum specimens.
    PLoS One. 2021;16:e0251602.
    PubMed     Abstract available


  223. KABIR S, Parash MTH, Emran NA, Hossain ABMT, et al
    Diagnostic challenges and Gene-Xpert utility in detecting Mycobacterium tuberculosis among suspected cases of Pulmonary tuberculosis.
    PLoS One. 2021;16:e0251858.
    PubMed     Abstract available


  224. HIRSCH-MOVERMAN Y, Howard AA, Mantell JE, Lebelo L, et al
    Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study.
    PLoS One. 2021;16:e0248516.
    PubMed     Abstract available


  225. WOOD RC, Andama A, Hermansky G, Burkot S, et al
    Characterization of oral swab samples for diagnosis of pulmonary tuberculosis.
    PLoS One. 2021;16:e0251422.
    PubMed     Abstract available


  226. BERRA TZ, Gomes D, Ramos ACV, Alves YM, et al
    Effectiveness and trend forecasting of tuberculosis diagnosis after the introduction of GeneXpert in a city in south-eastern Brazil.
    PLoS One. 2021;16:e0252375.
    PubMed     Abstract available


  227. VASANTHA M, Muniyandi M, Ponnuraja C, Srinivasan R, et al
    Bayesian structural equation modeling for post treatment health related quality of life among tuberculosis patients.
    PLoS One. 2021;16:e0252205.
    PubMed     Abstract available


  228. SHIFERAW MB, Sinishaw MA, Amare D, Alem G, et al
    Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia.
    PLoS One. 2021;16:e0253177.
    PubMed     Abstract available


  229. YANG H, Yang Y, Hu ZD, Xia L, et al
    High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
    PLoS One. 2021;16:e0253159.
    PubMed     Abstract available


  230. SINGPANOMCHAI N, Akeda Y, Tomono K, Tamaru A, et al
    Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection.
    PLoS One. 2021;16:e0253235.
    PubMed     Abstract available


  231. SYLVERKEN AA, Kwarteng A, Twumasi-Ankrah S, Owusu M, et al
    The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.
    PLoS One. 2021;16:e0252819.
    PubMed     Abstract available


  232. ARCENCIO RA, Berra TZ, Terena NFM, Rocha MP, et al
    Spatial clustering and temporal trend analysis of international migrants diagnosed with tuberculosis in Brazil.
    PLoS One. 2021;16:e0252712.
    PubMed     Abstract available


  233. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed     Abstract available



  234. Retraction: The Clinical Outcomes of Surgical Treatment of Noncontiguous Spinal Tuberculosis: A Retrospective Study in 23 Cases.
    PLoS One. 2021;16:e0253035.
    PubMed    


  235. THOMAS BE, Thiruvengadam K, Vedhachalam C, A S, et al
    Prevalence of pulmonary tuberculosis among the tribal populations in India.
    PLoS One. 2021;16:e0251519.
    PubMed     Abstract available


  236. QADER GQ, Seddiq MK, Rashidi KM, Manzoor L, et al
    Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study.
    PLoS One. 2021;16:e0252307.
    PubMed     Abstract available


  237. MUSAKWA NO, Bor J, Nattey C, Lonnermark E, et al
    Perceived barriers to the uptake of health services among first-year university students in Johannesburg, South Africa.
    PLoS One. 2021;16:e0245427.
    PubMed     Abstract available


  238. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed     Abstract available


  239. LIANG T, Chen J, Xu G, Zhang Z, et al
    Immune status changing helps diagnose osteoarticular tuberculosis.
    PLoS One. 2021;16:e0252875.
    PubMed     Abstract available


  240. OSMAN M, Meehan SA, von Delft A, Du Preez K, et al
    Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa.
    PLoS One. 2021;16:e0252084.
    PubMed     Abstract available


  241. PAN SW, Su WJ, Chan YJ, Chuang FY, et al
    Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection.
    PLoS One. 2021;16:e0253879.
    PubMed     Abstract available


  242. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Comparative accuracy of pleural fluid unstimulated interferon-gamma and adenosine deaminase for diagnosing pleural tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253525.
    PubMed     Abstract available


  243. YU G, Shen Y, Ye B, Shi Y, et al
    Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253658.
    PubMed     Abstract available


  244. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed     Abstract available


  245. CHAI J, Wang Q, Qin B, Wang S, et al
    Association of NOS2A gene polymorphisms with susceptibility to bovine tuberculosis in Chinese Holstein cattle.
    PLoS One. 2021;16:e0253339.
    PubMed     Abstract available


  246. MOHIDEM NA, Osman M, Hashim Z, Muharam FM, et al
    Association of sociodemographic and environmental factors with spatial distribution of tuberculosis cases in Gombak, Selangor, Malaysia.
    PLoS One. 2021;16:e0252146.
    PubMed     Abstract available


  247. LAZZARI TK, Cavalheiro E, Coutinho SE, da Silva LF, et al
    Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients.
    PLoS One. 2021;16:e0254198.
    PubMed     Abstract available


  248. OUDGHIRI A, Momen G, Aainouss A, Laglaoui A, et al
    Genotypic diversity of multi- and pre-extremely drug-resistant Mycobacterium tuberculosis isolates from Morocco.
    PLoS One. 2021;16:e0253826.
    PubMed     Abstract available


  249. ALMAW G, Conlan AJK, Ameni G, Gumi B, et al
    The variable prevalence of bovine tuberculosis among dairy herds in Central Ethiopia provides opportunities for targeted intervention.
    PLoS One. 2021;16:e0254091.
    PubMed     Abstract available


  250. OBSA MS, Daga WB, Wosene NG, Gebremedhin TD, et al
    Treatment seeking delay and associated factors among tuberculosis patients attending health facility in Ethiopia from 2000 to 2020: A systematic review and meta analysis.
    PLoS One. 2021;16:e0253746.
    PubMed     Abstract available


  251. DAWIT Z, Abebe S, Dessu S, Mesele M, et al
    Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia.
    PLoS One. 2021;16:e0253449.
    PubMed     Abstract available


  252. ALEMU A, Bitew ZW, Worku T, Gamtesa DF, et al
    Predictors of mortality in patients with drug-resistant tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253848.
    PubMed     Abstract available


  253. CRECELIUS EM, Lustik MB, Horseman TS, Jones MU, et al
    The prevalence of M. tuberculosis among acid fast bacilli cultures from military health system and veterans affairs beneficiaries in Hawaii and the Pacific Islands from 2002 to 2019.
    PLoS One. 2021;16:e0254312.
    PubMed     Abstract available


  254. CUONG NK, Ngoc NB, Hoa NB, Dat VQ, et al
    GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis.
    PLoS One. 2021;16:e0253961.
    PubMed     Abstract available


  255. TADOKERA R, Huo S, Theron G, Timire C, et al
    Health care seeking patterns of rifampicin-resistant tuberculosis patients in Harare, Zimbabwe: A prospective cohort study.
    PLoS One. 2021;16:e0254204.
    PubMed     Abstract available


  256. TANG J, Huang Y, Cai Z, Ma Y, et al
    Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-gamma release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0254571.
    PubMed     Abstract available


  257. MAOKOLA WM, Ngowi BJ, Mahande MJ, Todd J, et al
    Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
    PLoS One. 2021;16:e0254082.
    PubMed     Abstract available


  258. SHAYO FK, Shayo SC
    Readiness of healthcare facilities with tuberculosis services to manage diabetes mellitus in Tanzania: A nationwide analysis for evidence-informed policy-making in high burden settings.
    PLoS One. 2021;16:e0254349.
    PubMed     Abstract available


  259. BOAH M, Kpordoxah MR, Adokiya MN
    Self-reported gender differentials in the knowledge of tuberculosis transmission and curative possibility using national representative data in Ghana.
    PLoS One. 2021;16:e0254499.
    PubMed     Abstract available


  260. SAMUELS THA, Wyss R, Ongarello S, Moore DAJ, et al
    Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis.
    PLoS One. 2021;16:e0254002.
    PubMed     Abstract available


  261. TAYE H, Alemu K, Mihret A, Ayalew S, et al
    Epidemiology of Mycobacterium tuberculosis lineages and strain clustering within urban and peri-urban settings in Ethiopia.
    PLoS One. 2021;16:e0253480.
    PubMed     Abstract available


  262. SALCEDO J, Rosales M, Kim JS, Nuno D, et al
    Cost-effectiveness of artificial intelligence monitoring for active tuberculosis treatment: A modeling study.
    PLoS One. 2021;16:e0254950.
    PubMed     Abstract available


  263. ARJA A, Godana W, Hassen H, Bogale B, et al
    Patient delay and associated factors among tuberculosis patients in Gamo zone public health facilities, Southern Ethiopia: An institution-based cross-sectional study.
    PLoS One. 2021;16:e0255327.
    PubMed     Abstract available


  264. SCORDO JM, Aguillon-Duran GP, Ayala D, Quirino-Cerrillo AP, et al
    A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.
    PLoS One. 2021;16:e0255194.
    PubMed     Abstract available


  265. CONNELLY JT, Andama A, Grant BD, Ball A, et al
    Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients.
    PLoS One. 2021;16:e0254156.
    PubMed     Abstract available


  266. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Mutunga L, et al
    Novel health system strategies for tuberculin skin testing at primary care clinics: Performance assessment and health economic evaluation.
    PLoS One. 2021;16:e0246523.
    PubMed     Abstract available


  267. IM C, Kim Y
    Spatial pattern of tuberculosis (TB) and related socio-environmental factors in South Korea, 2008-2016.
    PLoS One. 2021;16:e0255727.
    PubMed     Abstract available


  268. ISLAM SS, Rumi TB, Kabir SML, van der Zanden AGM, et al
    Correction: Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh.
    PLoS One. 2021;16:e0256042.
    PubMed     Abstract available


  269. KUMAR SK, Arya S, Singh A, Misra R, et al
    Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
    PLoS One. 2021;16:e0255639.
    PubMed     Abstract available


  270. ALISJAHBANA B, Koesoemadinata RC, Hadisoemarto PF, Lestari BW, et al
    Are neighbourhoods of tuberculosis cases a high-risk population for active intervention? A protocol for tuberculosis active case finding.
    PLoS One. 2021;16:e0256043.
    PubMed     Abstract available


  271. DHAKULKAR S, Das M, Sutar N, Oswal V, et al
    Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
    PLoS One. 2021;16:e0246639.
    PubMed     Abstract available


  272. FOREMAN HC, Frank A, Stedman TT
    Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors.
    PLoS One. 2021;16:e0256079.
    PubMed     Abstract available


  273. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0256717.
    PubMed     Abstract available


  274. KHAN IA, Nayak B, Markandey M, Bajaj A, et al
    Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis.
    PLoS One. 2021;16:e0256098.
    PubMed     Abstract available


  275. NATHAVITHARANA RR, van der Westhuizen A, van der Westhuizen HM, Mishra H, et al
    "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment.
    PLoS One. 2021;16:e0254211.
    PubMed     Abstract available


  276. MURALI S, Krishnamoorthy Y, Knudsen S, Roy G, et al
    Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India.
    PLoS One. 2021;16:e0256773.
    PubMed     Abstract available


  277. OHARA Y, Ozeki Y, Tateishi Y, Mashima T, et al
    Correction: Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.
    PLoS One. 2021;16:e0256946.
    PubMed     Abstract available


  278. OSEI-WUSU S, Otchere ID, Morgan P, Musah AB, et al
    Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.
    PLoS One. 2021;16:e0255433.
    PubMed     Abstract available


  279. CHETTY-MAKKAN CM, deSanto D, Lessells R, Charalambous S, et al
    Exploring the promise and reality of ward-based primary healthcare outreach teams conducting TB household contact tracing in three districts of South Africa.
    PLoS One. 2021;16:e0256033.
    PubMed     Abstract available


  280. LOXTON NW, Rohlwink UK, Tshavhungwe M, Dlamini L, et al
    A pilot study of inflammatory mediators in brain extracellular fluid in paediatric TBM.
    PLoS One. 2021;16:e0246997.
    PubMed     Abstract available


  281. ORESKOVIC A, Lutz BR
    Ultrasensitive hybridization capture: Reliable detection of <1 copy/mL short cell-free DNA from large-volume urine samples.
    PLoS One. 2021;16:e0247851.
    PubMed     Abstract available


  282. THAPA P, Jayasuriya R, Hall JJ, Beek K, et al
    Role of informal healthcare providers in tuberculosis care in low- and middle-income countries: A systematic scoping review.
    PLoS One. 2021;16:e0256795.
    PubMed     Abstract available


  283. KERKHOFF AD, Kagujje M, Nyangu S, Mateyo K, et al
    Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment.
    PLoS One. 2021;16:e0252095.
    PubMed     Abstract available


  284. BUTTLE TS, Hummerstone CY, Billahalli T, Ward RJB, et al
    The monocyte-to-lymphocyte ratio: Sex-specific differences in the tuberculosis disease spectrum, diagnostic indices and defining normal ranges.
    PLoS One. 2021;16:e0247745.
    PubMed     Abstract available


  285. JO Y, Kagujje M, Johnson K, Dowdy D, et al
    Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia.
    PLoS One. 2021;16:e0256531.
    PubMed     Abstract available


  286. NGOC NB, Vu Dinh H, Thuy NT, Quang DV, et al
    Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam.
    PLoS One. 2021;16:e0255357.
    PubMed     Abstract available


  287. GOTHAM D, McKenna L, Deborggraeve S, Madoori S, et al
    Public investments in the development of GeneXpert molecular diagnostic technology.
    PLoS One. 2021;16:e0256883.
    PubMed     Abstract available


  288. DEVALRAJU KP, Neela VSK, Krovvidi SS, Vankayalapati R, et al
    Defective expansion and function of memory like natural killer cells in HIV+ individuals with latent tuberculosis infection.
    PLoS One. 2021;16:e0257185.
    PubMed     Abstract available


  289. GALLUCCI G, Santucci N, Diaz A, Bongiovanni B, et al
    Increased levels of circulating LPS during Tuberculosis prevails in patients with advanced pulmonary involvement.
    PLoS One. 2021;16:e0257214.
    PubMed     Abstract available


  290. KIMANI E, Muhula S, Kiptai T, Orwa J, et al
    Factors influencing TB treatment interruption and treatment outcomes among patients in Kiambu County, 2016-2019.
    PLoS One. 2021;16:e0248820.
    PubMed     Abstract available


  291. PANRAKSA Y, Amin AG, Graham B, Henry CS, et al
    Immobilization of Proteinase K for urine pretreatment to improve diagnostic accuracy of active tuberculosis.
    PLoS One. 2021;16:e0257615.
    PubMed     Abstract available


  292. GOPALAN N, Srinivasalu VA, Chinnayan P, Velayutham B, et al
    Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
    PLoS One. 2021;16:e0257647.
    PubMed     Abstract available


  293. WATURUOCHA UW, P J A, Singh KK, Malhotra V, et al
    A high-frequency single nucleotide polymorphism in the MtrB sensor kinase in clinical strains of Mycobacterium tuberculosis alters its biochemical and physiological properties.
    PLoS One. 2021;16:e0256664.
    PubMed     Abstract available


  294. TAMENE W, Abebe M, Wassie L, Mollalign H, et al
    PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV.
    PLoS One. 2021;16:e0258122.
    PubMed     Abstract available


  295. ZVONAREVA O, Witte S, Kabanets N, Filinyuk O, et al
    Adolescents in a tuberculosis hospital: Qualitative study of how relationships with doctors, caregivers, and peers mediate their mental wellbeing.
    PLoS One. 2021;16:e0257379.
    PubMed     Abstract available


  296. NABITY SA, Gunde LJ, Surie D, Shiraishi RW, et al
    Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
    PLoS One. 2021;16:e0248115.
    PubMed     Abstract available


  297. DIRIBA G, Tola HH, Alemu A, Yenew B, et al
    Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0258295.
    PubMed     Abstract available


  298. SANCHEZ-CORRALES L, Tovar-Aguirre OL, Galeano-Vanegas NF, Castano Jimenez PA, et al
    Phylogenomic analysis and Mycobacterium tuberculosis antibiotic resistance prediction by whole-genome sequencing from clinical isolates of Caldas, Colombia.
    PLoS One. 2021;16:e0258402.
    PubMed     Abstract available


  299. SUN L, Chen Y, Yi P, Yang L, et al
    Serological detection of Mycobacterium Tuberculosis complex infection in multiple hosts by One Universal ELISA.
    PLoS One. 2021;16:e0257920.
    PubMed     Abstract available


  300. WELEKIDAN LN, Skjerve E, Dejene TA, Gebremichael MW, et al
    Correction: Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    PLoS One. 2021;16:e0258457.
    PubMed     Abstract available


  301. DOLLA CK, Dhanaraj B, Chandrasekaran P, Selvaraj S, et al
    Prevalence of bacteriologically confirmed pulmonary tuberculosis and associated risk factors: A community survey in Thirvallur District, south India.
    PLoS One. 2021;16:e0247245.
    PubMed     Abstract available


  302. VON BOTH U, Gerlach P, Ritz N, Bogyi M, et al
    Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany, Austria and Switzerland.
    PLoS One. 2021;16:e0250387.
    PubMed     Abstract available


  303. APPIAH PK, Osei B, Amu H
    Factors associated with nutritional status, knowledge and attitudes among tuberculosis patients receiving treatment in Ghana: A cross-sectional study in the Tema Metropolis.
    PLoS One. 2021;16:e0258033.
    PubMed     Abstract available


  304. ALI MA, Balcha ES, Woldesemayat AA, Tirore LD, et al
    Combined assessment of tuberculosis case notification rate and infection control at health facilities of Dale districts, Sidama Zone, Southern Ethiopia.
    PLoS One. 2021;16:e0242446.
    PubMed     Abstract available


  305. ALLIE T, Jackson A, Ambler J, Johnston K, et al
    TBDBT: A TB DataBase Template for collection of harmonized TB clinical research data in REDCap, facilitating data standardisation for inter-study comparison and meta-analyses.
    PLoS One. 2021;16:e0249165.
    PubMed     Abstract available


  306. SPEKKER O, Hunt DR, Berthon W, Paja L, et al
    Tracking down the White Plague. Chapter three: Revision of endocranial abnormally pronounced digital impressions as paleopathological diagnostic criteria for tuberculous meningitis.
    PLoS One. 2021;16:e0249020.
    PubMed     Abstract available


  307. HOFFMANN J, Chedid C, Ocheretina O, Masetti C, et al
    Drug-resistant TB prevalence study in 5 health institutions in Haiti.
    PLoS One. 2021;16:e0248707.
    PubMed     Abstract available


  308. SINGH AR, Kumar A, Shewade HD, Dhingra B, et al
    Poor adherence to TB diagnosis guidelines among under-five children with severe acute malnutrition in central India: A missed window of opportunity?
    PLoS One. 2021;16:e0248192.
    PubMed     Abstract available


  309. DAS M, Mathur T, Ravi S, Meneguim AC, et al
    Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study.
    PLoS One. 2021;16:e0248408.
    PubMed     Abstract available


  310. GEIGER K, Stamper PD, Farley JE
    The effects of MDR/RR-TB treatment on HIV disease: A systematic review of literature.
    PLoS One. 2021;16:e0248174.
    PubMed     Abstract available


  311. SAHILE Z, Tezera R, Haile Mariam D, Collins J, et al
    Nutritional status and TB treatment outcomes in Addis Ababa, Ethiopia: An ambi-directional cohort study.
    PLoS One. 2021;16:e0247945.
    PubMed     Abstract available


  312. LOVEDAY M, Hlangu S, Larkan LM, Cox H, et al
    "This is not my body": Therapeutic experiences and post-treatment health of people with rifampicin-resistant tuberculosis.
    PLoS One. 2021;16:e0251482.
    PubMed     Abstract available


  313. NOVIYANI A, Nopsopon T, Pongpirul K
    Variation of tuberculosis prevalence across diagnostic approaches and geographical areas of Indonesia.
    PLoS One. 2021;16:e0258809.
    PubMed     Abstract available


  314. MANYELO CM, Chegou NN, Seddon JA, Snyders CI, et al
    Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis.
    PLoS One. 2021;16:e0250944.
    PubMed     Abstract available


  315. MICHENI LN, Kassaza K, Kinyi H, Ntulume I, et al
    Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
    PLoS One. 2021;16:e0259221.
    PubMed     Abstract available


  316. BADA FO, Blok N, Okpokoro E, Dutt S, et al
    Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2021;16:e0259492.
    PubMed     Abstract available


  317. FLORENTINI EA, Angulo N, Gilman RH, Alcantara R, et al
    Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0259439.
    PubMed     Abstract available


  318. CUEVAS-CORDOBA B, Fresno C, Haase-Hernandez JI, Barbosa-Amezcua M, et al
    A bioinformatics pipeline for Mycobacterium tuberculosis sequencing that cleans contaminant reads from sputum samples.
    PLoS One. 2021;16:e0258774.
    PubMed     Abstract available


  319. KASO AW, Hailu A
    Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    PLoS One. 2021;16:e0259056.
    PubMed     Abstract available


  320. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259006.
    PubMed     Abstract available


  321. JAIN J, Jadhao P, Banait S, Salunkhe P, et al
    Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion.
    PLoS One. 2021;16:e0251618.
    PubMed     Abstract available


  322. WITTE C, Fowler JH, Pfeiffer W, Hungerford LL, et al
    Social network analysis and whole-genome sequencing to evaluate disease transmission in a large, dynamic population: A study of avian mycobacteriosis in zoo birds.
    PLoS One. 2021;16:e0252152.
    PubMed     Abstract available


  323. YU G, Zhong F, Shen Y, Zheng H, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for tuberculous pericarditis: A protocol of systematic review and meta-analysis.
    PLoS One. 2021;16:e0252109.
    PubMed     Abstract available


  324. THOMAS BE, Thiruvengadam K, S R, Rani S, et al
    Understanding health care-seeking behaviour of the tribal population in India among those with presumptive TB symptoms.
    PLoS One. 2021;16:e0250971.
    PubMed     Abstract available


  325. GARCIA-ZAMALLOA A, Vicente D, Arnay R, Arrospide A, et al
    Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study.
    PLoS One. 2021;16:e0259203.
    PubMed     Abstract available


  326. CLOETE R, Shahbaaz M, Grobbelaar M, Sampson SL, et al
    In silico repurposing of a Novobiocin derivative for activity against latency associated Mycobacterium tuberculosis drug target nicotinate-nucleotide adenylyl transferase (Rv2421c).
    PLoS One. 2021;16:e0259348.
    PubMed     Abstract available


  327. ASSEFA G, Desta K, Araya S, Girma S, et al
    Diagnostic efficacy of Light-Emitting Diode (LED) Fluorescence based Microscope for the diagnosis of Tuberculous lymphadenitis.
    PLoS One. 2021;16:e0255146.
    PubMed     Abstract available


  328. GAUGHRAN A, Mullen E, MacWhite T, Maher P, et al
    Badger territoriality maintained despite disturbance of major road construction.
    PLoS One. 2021;16:e0242586.
    PubMed     Abstract available


  329. SAMUELS THA, Shete PB, Ojok C, Nalugwa T, et al
    Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda.
    PLoS One. 2021;16:e0253927.
    PubMed     Abstract available


  330. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Van Rie A, et al
    Association between monocyte-to-lymphocyte ratio and tuberculin skin test positivity in HIV-positive adults.
    PLoS One. 2021;16:e0253907.
    PubMed     Abstract available


  331. ACEN EL, Biraro IA, Worodria W, Joloba ML, et al
    Impact of vitamin D status and cathelicidin antimicrobial peptide on adults with active pulmonary TB globally: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0252762.
    PubMed     Abstract available


  332. AYABINA DV, Gomes MGM, Nguyen NV, Vo L, et al
    The impact of active case finding on transmission dynamics of tuberculosis: A modelling study.
    PLoS One. 2021;16:e0257242.
    PubMed     Abstract available


  333. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed     Abstract available


  334. PAPADOPOULOS AO, Ealand C, Gordhan BG, VanNieuwenhze M, et al
    Characterisation of a putative M23-domain containing protein in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0259181.
    PubMed     Abstract available


  335. AMBREEN A, Tahseen S, Wali A, Jamil M, et al
    Predictors of slow clinical response and extended treatment in patients with extra-pulmonary tuberculosis in Pakistan, A hospital-based prospective study.
    PLoS One. 2021;16:e0259801.
    PubMed     Abstract available


  336. SULMAN S, Shahid S, Khaliq A, Ambreen A, et al
    Enhanced serodiagnostic potential of a fusion molecule consisting of Rv1793, Rv2628 and a truncated Rv2608 of Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0258389.
    PubMed     Abstract available


  337. KATHAMUTHU GR, Moideen K, Sridhar R, Baskaran D, et al
    Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis.
    PLoS One. 2021;16:e0253534.
    PubMed     Abstract available


  338. ALKABAB YMA, Biswas S, Ahmed S, Paul K, et al
    Differentiating transient from persistent diabetic range hyperglycemia in a cohort of people completing tuberculosis treatment in Dhaka, Bangladesh.
    PLoS One. 2021;16:e0260389.
    PubMed     Abstract available


  339. NARH-BANA SA, Kawonga M, Chirwa ED, Ibisomi L, et al
    Fidelity of implementation of TB screening guidelines by health providers at selected HIV clinics in Ghana.
    PLoS One. 2021;16:e0257486.
    PubMed     Abstract available


  340. YU G, Zhong F, Shen Y, Zheng H, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for tuberculous pericarditis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0257220.
    PubMed     Abstract available


  341. OWUSU AY, Kushitor SB, Ofosu AA, Kushitor MK, et al
    Institutional mortality rate and cause of death at health facilities in Ghana between 2014 and 2018.
    PLoS One. 2021;16:e0256515.
    PubMed     Abstract available


  342. WEKUNDA PW, Aduda DSO, Guyah B
    Determinants of tuberculosis treatment interruption among patients in Vihiga County, Kenya.
    PLoS One. 2021;16:e0260669.
    PubMed     Abstract available


  343. GEORGHIOU SB, Alagna R, Cirillo DM, Carmona S, et al
    Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection.
    PLoS One. 2021;16:e0261442.
    PubMed     Abstract available


  344. EDESSA D, Adem F, Hagos B, Sisay M, et al
    Incidence and predictors of mortality among persons receiving second-line tuberculosis treatment in sub-Saharan Africa: A meta-analysis of 43 cohort studies.
    PLoS One. 2021;16:e0261149.
    PubMed     Abstract available


  345. FOE-ESSOMBA JR, Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, et al
    Diabetes mellitus and tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders.
    PLoS One. 2021;16:e0261246.
    PubMed     Abstract available


  346. PAUDEL S, Padmawati RS, Ghimire A, Yonzon CL, et al
    Feasibility of Find cases Actively, Separate safely and Treat effectively (FAST) strategy for early diagnosis of TB in Nepal: An implementation research.
    PLoS One. 2021;16:e0258883.
    PubMed     Abstract available


  347. CANIVE M, Gonzalez-Recio O, Fernandez A, Vazquez P, et al
    Identification of loci associated with susceptibility to Mycobacterium avium subsp. paratuberculosis infection in Holstein cattle using combinations of diagnostic tests and imputed whole-genome sequence data.
    PLoS One. 2021;16:e0256091.
    PubMed     Abstract available


  348. GINA NSV, Rasweswe MM, Moagi MM
    Standard precautions for preventing Tuberculosis and HIV: Compliance of Eswatini university student nurses.
    PLoS One. 2021;16:e0261944.
    PubMed     Abstract available


  349. AFUM T, Asare P, Asante-Poku A, Darko-Otchere I, et al
    Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana.
    PLoS One. 2021;16:e0261849.
    PubMed     Abstract available


  350. MEAZA A, Tesfaye E, Mohamed Z, Zerihun B, et al
    Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0261084.
    PubMed     Abstract available


  351. RIBEIRO RM, Havik PJ, Craveiro I
    The circuits of healthcare: Understanding healthcare seeking behaviour-A qualitative study with tuberculosis patients in Lisbon, Portugal.
    PLoS One. 2021;16:e0261688.
    PubMed     Abstract available


  352. SAHILE Z, Perimal-Lewis L, Arbon P, Maeder AJ, et al
    Protocol of a parallel group Randomized Control Trial (RCT) for Mobile-assisted Medication Adherence Support (Ma-MAS) intervention among Tuberculosis patients.
    PLoS One. 2021;16:e0261758.
    PubMed     Abstract available


  353. CHANIE ES, Gelaye GA, Tadesse TY, Feleke DG, et al
    Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study.
    PLoS One. 2021;16:e0258964.
    PubMed     Abstract available


  354. VANQA N, Hoddinott G, Mbenyana B, Osman M, et al
    Linkage to TB care: A qualitative study to understand linkage from the patients' perspective in the Western Cape Province, South Africa.
    PLoS One. 2021;16:e0260200.
    PubMed     Abstract available


  355. DEMBELU M, Kote M, Gilano G, Mohammed T, et al
    Incidence and predictors of reoccurrence of opportunistic infection among adult HIV/AIDS patients attending ART clinic at public health facilities in Arba Minch town, southern Ethiopia: A retrospective cohort study.
    PLoS One. 2021;16:e0261454.
    PubMed     Abstract available


  356. RAHMAN SMM, Nasrin R, Rahman A, Ahmed S, et al
    Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
    PLoS One. 2021;16:e0261329.
    PubMed     Abstract available


  357. MISHRA P, Sharma RK, Yadav R, Rao VG, et al
    Reasons for loss to follow-up (LTFU) of pulmonary TB (PTB) patients: A qualitative study among Saharia, a particularly vulnerable tribal group of Madhya Pradesh, India.
    PLoS One. 2021;16:e0261152.
    PubMed     Abstract available


    January 2020
  358. MAIR L, Corbett EL, Feasey HRA, Kamchedzera W, et al
    Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi.
    PLoS One. 2020;15:e0236407.
    PubMed     Abstract available


  359. KALRA A, Parija D, Raizada N, Sachdeva KS, et al
    Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    PLoS One. 2020;15:e0236057.
    PubMed     Abstract available


  360. NACHER M, Adenis A, Guarmit B, Lucarelli A, et al
    What is AIDS in the Amazon and the Guianas in the 90-90-90 era?
    PLoS One. 2020;15:e0236368.
    PubMed     Abstract available


  361. ANKU PJ, Amo-Adjei J, Doku D, Kumi-Kyereme A, et al
    Challenges of scaling-up of TB-HIV integrated service delivery in Ghana.
    PLoS One. 2020;15:e0235843.
    PubMed     Abstract available


  362. SAYEDI SM, Seddiq MK, Rashidi MK, Qader G, et al
    Active household contact screening for tuberculosis and provision of isoniazid preventive therapy to under-five children in Afghanistan.
    PLoS One. 2020;15:e0240031.
    PubMed     Abstract available


  363. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    PubMed     Abstract available


  364. LINCE-DEROCHE N, Leuner R, Kgowedi S, Moolla A, et al
    Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa.
    PLoS One. 2020;15:e0230849.
    PubMed     Abstract available


  365. KRISHNAKUMARIAMMA K, Ellappan K, Muthuraj M, Tamilarasu K, et al
    Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    PLoS One. 2020;15:e0240257.
    PubMed     Abstract available


  366. SHIN HS, Choi DS, Na JB, Choi HY, et al
    Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: A comparison with primary drug sensitive tuberculosis.
    PLoS One. 2020;15:e0239431.
    PubMed     Abstract available


  367. SALA C, Benjak A, Goletti D, Banu S, et al
    Multicenter analysis of sputum microbiota in tuberculosis patients.
    PLoS One. 2020;15:e0240250.
    PubMed     Abstract available


  368. TING NCH, El-Turk N, Chou MSH, Dobler CC, et al
    Patient-perceived treatment burden of tuberculosis treatment.
    PLoS One. 2020;15:e0241124.
    PubMed     Abstract available


  369. TAN C, Kallon II, Colvin CJ, Grant AD, et al
    Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review.
    PLoS One. 2020;15:e0241039.
    PubMed     Abstract available


  370. NGUIPDOP-DJOMO P, Rodrigues LC, Abubakar I, Mangtani P, et al
    Small-area level socio-economic deprivation and tuberculosis rates in England: An ecological analysis of tuberculosis notifications between 2008 and 2012.
    PLoS One. 2020;15:e0240879.
    PubMed     Abstract available


  371. BROOKS MB, Mitnick CD, Manjourides J
    Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses.
    PLoS One. 2020;15:e0240297.
    PubMed     Abstract available


  372. MBUTHIA GW, Nyamogoba HDN, Chiang SS, McGarvey ST, et al
    Burden of stigma among tuberculosis patients in a pastoralist community in Kenya: A mixed methods study.
    PLoS One. 2020;15:e0240457.
    PubMed     Abstract available


  373. VELAYUTHAM B, Jayabal L, Watson B, Jagadeesan S, et al
    Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
    PLoS One. 2020;15:e0240594.
    PubMed     Abstract available


  374. MERID MW, Muluneh AG, Yenit MK, Kassa GM, et al
    Treatment interruption and associated factors among patients registered on drug-resistant tuberculosis treatment in Amhara regional state, Ethiopia: 2010-2017.
    PLoS One. 2020;15:e0240564.
    PubMed     Abstract available


  375. KAGUJJE M, Chilukutu L, Somwe P, Mutale J, et al
    Active TB case finding in a high burden setting; comparison of community and facility-based strategies in Lusaka, Zambia.
    PLoS One. 2020;15:e0237931.
    PubMed     Abstract available


  376. ALAO MA, Maroushek SR, Chan YH, Asinobi AO, et al
    Treatment outcomes of Nigerian patients with tuberculosis: A retrospective 25-year review in a regional medical center.
    PLoS One. 2020;15:e0239225.
    PubMed     Abstract available


  377. RAMOS-SONO D, Laureano R, Rueda D, Gilman RH, et al
    An electrochemical biosensor for the detection of Mycobacterium tuberculosis DNA from sputum and urine samples.
    PLoS One. 2020;15:e0241067.
    PubMed     Abstract available


  378. BIERMANN O, Tran PB, Viney K, Caws M, et al
    Active case-finding policy development, implementation and scale-up in high-burden countries: A mixed-methods survey with National Tuberculosis Programme managers and document review.
    PLoS One. 2020;15:e0240696.
    PubMed     Abstract available


  379. SZIGETI R, Kellermayer D, Trakimas G, Kellermayer R, et al
    BCG epidemiology supports its protection against COVID-19? A word of caution.
    PLoS One. 2020;15:e0240203.
    PubMed     Abstract available


  380. SPEKKER O, Schultz M, Paja L, Varadi OA, et al
    Tracking down the White Plague. Chapter two: The role of endocranial abnormal blood vessel impressions and periosteal appositions in the paleopathological diagnosis of tuberculous meningitis.
    PLoS One. 2020;15:e0238444.
    PubMed     Abstract available


  381. FLORENTINI EA, Angulo N, Gilman RH, Alcantara R, et al
    Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0241600.
    PubMed     Abstract available


  382. WAHEDI K, Biddle L, Bozorgmehr K
    Cost-effectiveness of targeted screening for active pulmonary tuberculosis among asylum-seekers: A modelling study with screening data from a German federal state (2002-2015).
    PLoS One. 2020;15:e0241852.
    PubMed     Abstract available


  383. WASIHUN AG, Dejene TA, Hailu GG
    Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
    PLoS One. 2020;15:e0240361.
    PubMed     Abstract available


  384. GOTHAM D, McKenna L, Frick M, Lessem E, et al
    Public investments in the clinical development of bedaquiline.
    PLoS One. 2020;15:e0239118.
    PubMed     Abstract available


  385. BALOGUN OS, Gao XZ, Jolayemi ET, Olaleye SA, et al
    Generalized cure rate model for infectious diseases with possible co-infections.
    PLoS One. 2020;15:e0239003.
    PubMed     Abstract available


  386. CHITTAMANY P, Yamanaka T, Suthepmany S, Sorsavanh T, et al
    First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    PLoS One. 2020;15:e0241862.
    PubMed     Abstract available


  387. BASTOS HN, Osorio NS, Castro AG, Ramos A, et al
    Correction: A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis.
    PLoS One. 2020;15:e0242455.
    PubMed     Abstract available


  388. ISLAM SKS, Rumi TB, Kabir SML, van der Zanden AGM, et al
    Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh.
    PLoS One. 2020;15:e0241717.
    PubMed     Abstract available


  389. GEZAHEGN LK, Argaw E, Assefa B, Geberesilassie A, et al
    Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0241346.
    PubMed     Abstract available


  390. BONNEWELL JP, Farrow L, Dicks KV, Cox GM, et al
    Geographic analysis of latent tuberculosis screening: A health system approach.
    PLoS One. 2020;15:e0242055.
    PubMed     Abstract available


  391. WANG N, Shewade HD, Thekkur P, Zhang H, et al
    Do electronic medication monitors improve tuberculosis treatment outcomes? Programmatic experience from China.
    PLoS One. 2020;15:e0242112.
    PubMed     Abstract available


  392. WIARDA JE, Boggiatto PM, Bayles DO, Waters WR, et al
    Severity of bovine tuberculosis is associated with innate immune-biased transcriptional signatures of whole blood in early weeks after experimental Mycobacterium bovis infection.
    PLoS One. 2020;15:e0239938.
    PubMed     Abstract available


  393. MAYITO J, Meya DB, Rhein J, Sekaggya-Wiltshire C, et al
    Utility of the monocyte to lymphocyte ratio in diagnosing latent tuberculosis among HIV-infected individuals with a negative tuberculosis symptom screen.
    PLoS One. 2020;15:e0241786.
    PubMed     Abstract available


  394. BADE AB, Mega TA
    Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study.
    PLoS One. 2020;15:e0241684.
    PubMed     Abstract available


  395. SANOGO B, Ouermi AS, Barro M, Millogo A, et al
    Performance of a lymphocyte t interferon gamma test (Quantiferon-TB gold in tube) in the diagnosis of active tuberculosis in HIV-infected children.
    PLoS One. 2020;15:e0241789.
    PubMed     Abstract available


  396. DORJI T, Tshering T, Wangdi K
    Assessment of knowledge, attitude and practice on tuberculosis among teacher trainees of Samtse College of Education, Bhutan.
    PLoS One. 2020;15:e0241923.
    PubMed     Abstract available


  397. KUNDU J, Bakshi S, Joshi H, Bhadada SK, et al
    Proteomic profiling of peripheral blood mononuclear cells isolated from patients with tuberculosis and diabetes copathogenesis - A pilot study.
    PLoS One. 2020;15:e0233326.
    PubMed     Abstract available


  398. DARMA S, Ambara A, Aman AT, Annisa L, et al
    High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
    PLoS One. 2020;15:e0242542.
    PubMed     Abstract available


  399. KETEMA L, Dememew ZG, Assefa D, Gudina T, et al
    Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study.
    PLoS One. 2020;15:e0241977.
    PubMed     Abstract available


  400. FLINT L, Korkegian A, Parish T
    InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
    PLoS One. 2020;15:e0239354.
    PubMed     Abstract available


  401. WELDEMHRET L, Hailu A, Gebremedhn G, Bekuretsion H, et al
    Blinded rechecking of sputum smear microscopy performance in public health facilities in Tigray region, Northern Ethiopia: Retrospective cross sectional study.
    PLoS One. 2020;15:e0239342.
    PubMed     Abstract available


  402. HORTER S, Achar J, Gray N, Parpieva N, et al
    Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    PLoS One. 2020;15:e0242359.
    PubMed     Abstract available


  403. BANU S, Haque F, Ahmed S, Sultana S, et al
    Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh.
    PLoS One. 2020;15:e0241437.
    PubMed     Abstract available


  404. AJUDUA FI, Mash RJ
    Implementing active surveillance for TB-The views of managers in a resource limited setting, South Africa.
    PLoS One. 2020;15:e0239430.
    PubMed     Abstract available


  405. HAUK C, Schafermann S, Martus P, Muzafarova N, et al
    Quality assurance in anti-tuberculosis drug procurement by the Stop TB Partnership-Global Drug Facility: Procedures, costs, time requirements, and comparison of assay and dissolution results by manufacturers and by external analysis.
    PLoS One. 2020;15:e0243428.
    PubMed     Abstract available


  406. STOCKBRIDGE EL, Loethen AD, Annan E, Miller TL, et al
    Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
    PLoS One. 2020;15:e0243102.
    PubMed     Abstract available


  407. LI Y, Pang Y, Zhang T, Xian X, et al
    Genotypes of Mycobacterium tuberculosis isolates circulating in Shaanxi Province, China.
    PLoS One. 2020;15:e0242971.
    PubMed     Abstract available


  408. WANG D, Tong X, Wang L, Zhang S, et al
    The association between osteopontin and tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0242702.
    PubMed     Abstract available


  409. YU G, Zhao W, Shen Y, Zhu P, et al
    Metagenomic next generation sequencing for the diagnosis of tuberculosis meningitis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243161.
    PubMed     Abstract available


  410. BADA FO, Blok N, Okpokoro E, Dutt S, et al
    Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2020;15:e0241065.
    PubMed     Abstract available


  411. LIMSRIVILAI J, Lee CK, Prueksapanich P, Harinwan K, et al
    Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.
    PLoS One. 2020;15:e0242879.
    PubMed     Abstract available


  412. KITONSA PJ, Nalutaaya A, Mukiibi J, Nakasolya O, et al
    Evaluation of underweight status may improve identification of the highest-risk patients during outpatient evaluation for pulmonary tuberculosis.
    PLoS One. 2020;15:e0243542.
    PubMed     Abstract available


  413. MOHAMMEDHUSSEIN M, Hajure M, Shifa JE, Hassen TA, et al
    Perceived stigma among patient with pulmonary tuberculosis at public health facilities in southwest Ethiopia: A cross-sectional study.
    PLoS One. 2020;15:e0243433.
    PubMed     Abstract available


  414. DIRIBA G, Kebede A, Tola HH, Yenew B, et al
    Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    PLoS One. 2020;15:e0243493.
    PubMed     Abstract available


  415. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    PubMed     Abstract available


  416. KOLTE IV, Pereira L, Benites A, de Sousa IMC, et al
    The contribution of stigma to the transmission and treatment of tuberculosis in a hyperendemic indigenous population in Brazil.
    PLoS One. 2020;15:e0243988.
    PubMed     Abstract available


  417. AREGA B, Mersha A, Minda A, Getachew Y, et al
    Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia.
    PLoS One. 2020;15:e0243945.
    PubMed     Abstract available


  418. KOSGEI RJ, Callens S, Gichangi P, Temmerman M, et al
    Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya.
    PLoS One. 2020;15:e0243977.
    PubMed     Abstract available


  419. SHEN Y, Fang L, Ye B, Yu G, et al
    Meta-analysis of diagnostic accuracy of nucleic acid amplification tests for abdominal tuberculosis: A protocol.
    PLoS One. 2020;15:e0243765.
    PubMed     Abstract available


  420. GADICHERLA S, Krishnappa L, Madhuri B, Mitra SG, et al
    Envisioning a learning surveillance system for tuberculosis.
    PLoS One. 2020;15:e0243610.
    PubMed     Abstract available


  421. ALI N, Bello GL, Rossetti MLR, Krieger MA, et al
    Demonstration of a fast and easy sample-to-answer protocol for tuberculosis screening in point-of-care settings: A proof of concept study.
    PLoS One. 2020;15:e0242408.
    PubMed     Abstract available


  422. MEJIA-PAILLES G, Berrington A, McGrath N, Hosegood V, et al
    Trends in the prevalence and incidence of orphanhood in children and adolescents <20 years in rural KwaZulu-Natal South Africa, 2000-2014.
    PLoS One. 2020;15:e0238563.
    PubMed     Abstract available


  423. HOPKINS KL, Hlongwane KE, Otwombe K, Dietrich J, et al
    Does peer-navigated linkage to care work? A cross-sectional study of active linkage to care within an integrated non-communicable disease-HIV testing centre for adults in Soweto, South Africa.
    PLoS One. 2020;15:e0241014.
    PubMed     Abstract available


  424. LOVEDAY M, Hlangu S, Furin J
    "Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.
    PLoS One. 2020;15:e0242604.
    PubMed     Abstract available


  425. ZAWEDDE-MUYANJA S, Musaazi J, Manabe YC, Katamba A, et al
    Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
    PLoS One. 2020;15:e0241611.
    PubMed     Abstract available



  426. Correction: Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India.
    PLoS One. 2020;15:e0244914.
    PubMed     Abstract available


  427. NONGHANPHITHAK D, Kaewprasert O, Chaiyachat P, Reechaipichitkul W, et al
    Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    PLoS One. 2020;15:e0244829.
    PubMed     Abstract available


  428. PARK JW, Curtis JR, Lee H, Lee JK, et al
    Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids.
    PLoS One. 2020;15:e0244239.
    PubMed     Abstract available


  429. KASOZI S, Kirirabwa NS, Kimuli D, Luwaga H, et al
    Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    PLoS One. 2020;15:e0244451.
    PubMed     Abstract available


  430. DIAN S, Hermawan R, van Laarhoven A, Immaculata S, et al
    Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis.
    PLoS One. 2020;15:e0241974.
    PubMed     Abstract available


  431. ANANTHAKRISHNAN R, Thiagesan R, Auguesteen S, Karunakaran N, et al
    The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
    PLoS One. 2020;15:e0241203.
    PubMed     Abstract available


  432. BORNMANN L, Haunschild R, Patel VM
    Are papers addressing certain diseases perceived where these diseases are prevalent? The proposal to use Twitter data as social-spatial sensors.
    PLoS One. 2020;15:e0242550.
    PubMed     Abstract available


  433. DE MEDEIROS VLS, Santos FCF, Montenegro LML, Silva MDC, et al
    TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients.
    PLoS One. 2020;15:e0242098.
    PubMed     Abstract available


  434. KARANJA M, Kingwara L, Owiti P, Kirui E, et al
    Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    PLoS One. 2020;15:e0234588.
    PubMed     Abstract available


  435. SOMNUKE P, Ramlee R, Ratanapaiboon W, Thommaaksorn P, et al
    Factors influencing preoperative chest radiography request for elective endoscopic procedures among medical personnel.
    PLoS One. 2020;15:e0242140.
    PubMed     Abstract available


  436. KAY AW, Thivalapill N, Skinner D, Dube GS, et al
    Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
    PLoS One. 2020;15:e0243713.
    PubMed     Abstract available


  437. ISLAM MS, Chughtai AA, Nazneen A, Chowdhury KIA, et al
    A tuberculin skin test survey among healthcare workers in two public tertiary care hospitals in Bangladesh.
    PLoS One. 2020;15:e0243951.
    PubMed     Abstract available


  438. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS.
    PLoS One. 2020;15:e0244800.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: